Effect of Perinatal Antiretroviral Drug Exposure on Hematologic Values in HIV‐Uninfected Children: An Analysis of the Women and Infants Transmission Study
Susan E. Pacheco, Kenneth McIntosh(Boston University), Marc Foca(Albert Einstein College of Medicine), William T. Shearer(Baylor College of Medicine), Edward Handelsman(National Institutes of Health), Karen Hayani(University of Illinois Chicago, Rockford campus), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Clemente Díaz(University of Puerto Rico System), Mingjian Lu(Guangzhou Medical University), Margaret Frederick(Clinical Trials and Surveys Corporation)
Cited by 122
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828